Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (13)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Merrill, C. L.
Right arrow Articles by Morgan, K. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merrill, C. L.
Right arrow Articles by Morgan, K. T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Toxicological Sciences 68, 93-101 (2002)
Copyright © 2002 by the Society of Toxicology


MOLECULAR AND GENETIC TOXICOLOGY

Etomoxir-Induced Oxidative Stress in HepG2 Cells Detected by Differential Gene Expression Is Confirmed Biochemically

Christine L. Merrill*,{dagger},1, Hong Ni{dagger}, Lawrence W. Yoon{dagger}, Mark A. Tirmenstein{ddagger}, Padma Narayanan{ddagger}, Gina R. Benavides{dagger}, M. J. Easton{dagger}, Donald R. Creech{dagger}, Catherine X. Hu{ddagger}, David C. McFarland{ddagger}, Laura M. Hahn{ddagger}, Heath C. Thomas{ddagger} and Kevin T. Morgan{dagger}

* Department of Microbiology, Pathology and Parasitology, North Carolina State University, Raleigh, North Carolina 27606; {dagger} Toxicogenomic Mechanisms, GlaxoSmithKline, RTP, North Carolina 27709; and {ddagger} Cellular Pathology, GlaxoSmithKline, King of Prussia, Pennsylvania 19406

Although they are known to be effective antidiabetic agents, little is published about the toxic effects of carnitine palmitoyltransferase-1 (CPT-1) inhibitors, such as etomoxir (ET). These compounds inhibit mitochondrial fatty acid ß-oxidation by irreversibly binding to CPT-1 and preventing entry of long chain fatty acids into the mitochondrial matrix. Treatment of HepG2 cells with 1 mM etomoxir for 6 h caused significant modulations in the expression of several redox-related and cell cycle mRNAs as measured by microarray analysis. Upregulated mRNAs included heme oxygenase 1 (HO1), 8-oxoguanine DNA glycosylase 1 (OGG1), glutathione reductase (GSR), cyclin-dependent kinase inhibitor 1A (CDKN1 [p21waf1]) and Mn+ superoxide dismutase precursor (SOD2); while cytochrome P450 1A1 (CYP1A1) and heat shock 70kD protein 1 (HSPA1A) were downregulated. Real time quantitative PCR (RT-PCR) confirmed the significant changes in 4 of 4 mRNAs assayed (CYP1A1, HO1, GSR, CDKN1), and identified 3 additional mRNA changes; 2 redox-related genes, {gamma}-glutamate-cysteine ligase modifier subunit (GCLM) and thioredoxin reductase (TXNRD1) and 1 DNA replication gene, topoisomerase II{alpha} (TOP2A). Temporal changes in selected mRNA levels were examined by RT-PCR over 11 time points from 15 min to 24 h postdosing. CYP1A1 exhibited a 38-fold decrease by 4 h, which rebounded to a 39-fold increase by 20 h. GCLM and TXNRD1 exhibited 13- and 9-fold increases, respectively at 24 h. Etomoxir-induced oxidative stress and impaired mitochondrial energy metabolism were confirmed by a significant decrease in reduced glutathione (GSH), reduced/oxidized glutathione ratio (GSH/GSSG), mitochondrial membrane potential (MMP), and ATP levels, and by concurrent increase in oxidized glutathione (GSSG) and superoxide generation. This is the first report of oxidative stress caused by etomoxir.

Key Words: etomoxir; toxicity; oxirane-carboxylates; oxidative stress; gene expression.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Toxicol PatholHome page
A. E. M. Vickers
Characterization of Hepatic Mitochondrial Injury Induced by Fatty Acid Oxidation Inhibitors
Toxicol Pathol, January 1, 2009; 37(1): 78 - 88.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. L. Brooks, C. M. Trent, C. F. Raetzsch, K. Flurkey, G. Boysen, M. T. Perfetti, Y.-C. Jeong, S. Klebanov, K. B. Patel, V. R. Khodush, et al.
Low Utilization of Circulating Glucose after Food Withdrawal in Snell Dwarf Mice
J. Biol. Chem., November 30, 2007; 282(48): 35069 - 35077.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. T. Morgan, Z. Jayyosi, M. A. Hower, M. V. Pino, T. M. Connolly, K. Kotlenga, J. Lin, M. Wang, H.-L. Schmidts, M. S. Bonnefoi, et al.
The Hepatic Transcriptome as a Window on Whole-Body Physiology and Pathophysiology
Toxicol Pathol, January 1, 2005; 33(1): 136 - 145.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. T. Morgan, W. Casey, M. Easton, D. Creech, Hong Ni, L. Yoon, S. Anderson, C. W. Qualls JR, L. M. Crosby, A. Macpherson, et al.
Frequent Sampling Reveals Dynamic Responses by the Transcriptome to Routine Media Replacement in HepG2 Cells
Toxicol Pathol, June 1, 2003; 31(4): 448 - 461.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.